Loading…

Assessment of Knowledge, Attitude, and Practice Patterns in Pulmonary Arterial Hypertension among Cardiologists and Pulmonologists: Evidence from Turkey

: Pulmonary arterial hypertension (PAH) is a rare chronic disease of the small pulmonary arteries that causes right heart failure and death. Accurate management of PAH is necessary to decrease morbidity and mortality. Understanding current practices and perspectives on PAH is important. For this pur...

Full description

Saved in:
Bibliographic Details
Published in:Medicina (Kaunas, Lithuania) Lithuania), 2023-10, Vol.59 (10), p.1869
Main Authors: Günaydın, Fatma Esra, Belen, Erdal, Altın, Sedat, Demir, Ahmet Uğur, Güven, Gülden, Durmuş, Gündüz
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c511t-60d696660f280dfdeb3e4a36be60b81f8f3d934c37c660e82ea146980d7692623
container_end_page
container_issue 10
container_start_page 1869
container_title Medicina (Kaunas, Lithuania)
container_volume 59
creator Günaydın, Fatma Esra
Belen, Erdal
Altın, Sedat
Demir, Ahmet Uğur
Güven, Gülden
Durmuş, Gündüz
description : Pulmonary arterial hypertension (PAH) is a rare chronic disease of the small pulmonary arteries that causes right heart failure and death. Accurate management of PAH is necessary to decrease morbidity and mortality. Understanding current practices and perspectives on PAH is important. For this purpose, we intended to determine physicians' knowledge, attitudes, and practice patterns in adult pulmonary arterial hypertension (PAH) in Turkey. : Between January and February 2022, an online questionnaire was sent via e-mail to all cardiologists and pulmonologists who were members of the Turkish Society of Cardiology (TSC) and the Turkish Thoracic Society (TTS). : A total of 200 physicians (122 pulmonologists and 78 cardiologists) responded to the questionnaire. Cardiologists were more frequently involved in the primary diagnosis and treatment of PAH than pulmonologists (37.2% vs. 23.8%, = 0.042). More than half of the physicians had access to right heart catheterization. In mild/moderate PAH patients with a negative vasoreactivity test, the monotherapy option was most preferred (82.8%) and endothelin receptor antagonists (ERAs) were the most preferred group in these patients (73%). ERAs plus phosphodiesterase-5 inhibitors (PDE-5 INH) were the most preferred (69%) combination therapy, and prostacyclin analogues plus PDE-5 INH was preferred by only pulmonologists. : Overall, clinical management of patients with PAH complied with guideline recommendations. Effective clinical management of PAH in specialized centers that having right heart catheterization achieve better outcomes.
doi_str_mv 10.3390/medicina59101869
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_a9cbcc775d7d47d4874c43a49eae4cc7</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A772098967</galeid><doaj_id>oai_doaj_org_article_a9cbcc775d7d47d4874c43a49eae4cc7</doaj_id><sourcerecordid>A772098967</sourcerecordid><originalsourceid>FETCH-LOGICAL-c511t-60d696660f280dfdeb3e4a36be60b81f8f3d934c37c660e82ea146980d7692623</originalsourceid><addsrcrecordid>eNptksFuEzEQhlcIREvhzglZ4sKBFO_a8dpcqigqtKISOZSz5dizi8OuHezdorwJj8skaaukQmtpRzP__1kznqJ4W9JzxhT91IPz1gczVSUtpVDPitNScDlRJefPD-KT4lXOK0pZNa2rl8UJq6ViU1mfFn9nOUPOPYSBxIZ8C_FPB66Fj2Q2DH4YHUYmOLJIxg7eAlmYYYAUMvGBLMauj8GkDZklTHrTkavNGjAO2cdADFZbMjfJ-djF1uch72E730PqM7m88w4CwpsUe3I7pl-weV28aEyX4c39_6z48eXydn41ufn-9Xo-u5nYaVkOE0GdUEII2lSSusbBkgE3TCxB0KUsG9kwpxi3rLYoAlmBKblQqK2FqkTFzorrPddFs9Lr5HvsR0fj9S4RU6tNws470EbZpbV1PXW143hkzS1nhiswwLGArIs9az0u8WksDjWZ7gh6XAn-p27jnS6poFIwhoQP94QUf4-QB937bKHrTIA4Zl1Jie_Gldpe9v6JdBXHFHBWW1U1RY04ULUGO_ChiXix3UL1rK4rqqTaqc7_o8LPQe9tDNB4zB8Z6N5gU8w5QfPYZEn1djX109VEy7vD4TwaHnaR_QOpwuNH</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2882599767</pqid></control><display><type>article</type><title>Assessment of Knowledge, Attitude, and Practice Patterns in Pulmonary Arterial Hypertension among Cardiologists and Pulmonologists: Evidence from Turkey</title><source>Open Access: PubMed Central</source><source>Publicly Available Content (ProQuest)</source><creator>Günaydın, Fatma Esra ; Belen, Erdal ; Altın, Sedat ; Demir, Ahmet Uğur ; Güven, Gülden ; Durmuş, Gündüz</creator><creatorcontrib>Günaydın, Fatma Esra ; Belen, Erdal ; Altın, Sedat ; Demir, Ahmet Uğur ; Güven, Gülden ; Durmuş, Gündüz</creatorcontrib><description>: Pulmonary arterial hypertension (PAH) is a rare chronic disease of the small pulmonary arteries that causes right heart failure and death. Accurate management of PAH is necessary to decrease morbidity and mortality. Understanding current practices and perspectives on PAH is important. For this purpose, we intended to determine physicians' knowledge, attitudes, and practice patterns in adult pulmonary arterial hypertension (PAH) in Turkey. : Between January and February 2022, an online questionnaire was sent via e-mail to all cardiologists and pulmonologists who were members of the Turkish Society of Cardiology (TSC) and the Turkish Thoracic Society (TTS). : A total of 200 physicians (122 pulmonologists and 78 cardiologists) responded to the questionnaire. Cardiologists were more frequently involved in the primary diagnosis and treatment of PAH than pulmonologists (37.2% vs. 23.8%, = 0.042). More than half of the physicians had access to right heart catheterization. In mild/moderate PAH patients with a negative vasoreactivity test, the monotherapy option was most preferred (82.8%) and endothelin receptor antagonists (ERAs) were the most preferred group in these patients (73%). ERAs plus phosphodiesterase-5 inhibitors (PDE-5 INH) were the most preferred (69%) combination therapy, and prostacyclin analogues plus PDE-5 INH was preferred by only pulmonologists. : Overall, clinical management of patients with PAH complied with guideline recommendations. Effective clinical management of PAH in specialized centers that having right heart catheterization achieve better outcomes.</description><identifier>ISSN: 1648-9144</identifier><identifier>ISSN: 1010-660X</identifier><identifier>EISSN: 1648-9144</identifier><identifier>DOI: 10.3390/medicina59101869</identifier><identifier>PMID: 37893587</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Adult ; Cardiologists ; Cardiology ; Chronic diseases ; Clinical medicine ; diagnosis ; disease management ; Dyspnea ; education ; Endothelin ; guideline adherence ; Health Knowledge, Attitudes, Practice ; Hospitals ; Humans ; Hypertension, Pulmonary - etiology ; Lung transplants ; Medical diagnosis ; Medical societies ; Medicine ; Mortality ; Patient compliance ; Patients ; Phosphodiesterase 5 Inhibitors - therapeutic use ; Physicians ; Practice ; pulmonary arterial hypertension ; Pulmonary Arterial Hypertension - complications ; Pulmonary Arterial Hypertension - drug therapy ; Pulmonary arteries ; Pulmonary hypertension ; Pulmonologists ; questionnaire ; Questionnaires ; Society ; Surveys ; Turkey</subject><ispartof>Medicina (Kaunas, Lithuania), 2023-10, Vol.59 (10), p.1869</ispartof><rights>COPYRIGHT 2023 MDPI AG</rights><rights>2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2023 by the authors. 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c511t-60d696660f280dfdeb3e4a36be60b81f8f3d934c37c660e82ea146980d7692623</cites><orcidid>0000-0002-9268-1071</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2882599767/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2882599767?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37893587$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Günaydın, Fatma Esra</creatorcontrib><creatorcontrib>Belen, Erdal</creatorcontrib><creatorcontrib>Altın, Sedat</creatorcontrib><creatorcontrib>Demir, Ahmet Uğur</creatorcontrib><creatorcontrib>Güven, Gülden</creatorcontrib><creatorcontrib>Durmuş, Gündüz</creatorcontrib><title>Assessment of Knowledge, Attitude, and Practice Patterns in Pulmonary Arterial Hypertension among Cardiologists and Pulmonologists: Evidence from Turkey</title><title>Medicina (Kaunas, Lithuania)</title><addtitle>Medicina (Kaunas)</addtitle><description>: Pulmonary arterial hypertension (PAH) is a rare chronic disease of the small pulmonary arteries that causes right heart failure and death. Accurate management of PAH is necessary to decrease morbidity and mortality. Understanding current practices and perspectives on PAH is important. For this purpose, we intended to determine physicians' knowledge, attitudes, and practice patterns in adult pulmonary arterial hypertension (PAH) in Turkey. : Between January and February 2022, an online questionnaire was sent via e-mail to all cardiologists and pulmonologists who were members of the Turkish Society of Cardiology (TSC) and the Turkish Thoracic Society (TTS). : A total of 200 physicians (122 pulmonologists and 78 cardiologists) responded to the questionnaire. Cardiologists were more frequently involved in the primary diagnosis and treatment of PAH than pulmonologists (37.2% vs. 23.8%, = 0.042). More than half of the physicians had access to right heart catheterization. In mild/moderate PAH patients with a negative vasoreactivity test, the monotherapy option was most preferred (82.8%) and endothelin receptor antagonists (ERAs) were the most preferred group in these patients (73%). ERAs plus phosphodiesterase-5 inhibitors (PDE-5 INH) were the most preferred (69%) combination therapy, and prostacyclin analogues plus PDE-5 INH was preferred by only pulmonologists. : Overall, clinical management of patients with PAH complied with guideline recommendations. Effective clinical management of PAH in specialized centers that having right heart catheterization achieve better outcomes.</description><subject>Adult</subject><subject>Cardiologists</subject><subject>Cardiology</subject><subject>Chronic diseases</subject><subject>Clinical medicine</subject><subject>diagnosis</subject><subject>disease management</subject><subject>Dyspnea</subject><subject>education</subject><subject>Endothelin</subject><subject>guideline adherence</subject><subject>Health Knowledge, Attitudes, Practice</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Hypertension, Pulmonary - etiology</subject><subject>Lung transplants</subject><subject>Medical diagnosis</subject><subject>Medical societies</subject><subject>Medicine</subject><subject>Mortality</subject><subject>Patient compliance</subject><subject>Patients</subject><subject>Phosphodiesterase 5 Inhibitors - therapeutic use</subject><subject>Physicians</subject><subject>Practice</subject><subject>pulmonary arterial hypertension</subject><subject>Pulmonary Arterial Hypertension - complications</subject><subject>Pulmonary Arterial Hypertension - drug therapy</subject><subject>Pulmonary arteries</subject><subject>Pulmonary hypertension</subject><subject>Pulmonologists</subject><subject>questionnaire</subject><subject>Questionnaires</subject><subject>Society</subject><subject>Surveys</subject><subject>Turkey</subject><issn>1648-9144</issn><issn>1010-660X</issn><issn>1648-9144</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptksFuEzEQhlcIREvhzglZ4sKBFO_a8dpcqigqtKISOZSz5dizi8OuHezdorwJj8skaaukQmtpRzP__1kznqJ4W9JzxhT91IPz1gczVSUtpVDPitNScDlRJefPD-KT4lXOK0pZNa2rl8UJq6ViU1mfFn9nOUPOPYSBxIZ8C_FPB66Fj2Q2DH4YHUYmOLJIxg7eAlmYYYAUMvGBLMauj8GkDZklTHrTkavNGjAO2cdADFZbMjfJ-djF1uch72E730PqM7m88w4CwpsUe3I7pl-weV28aEyX4c39_6z48eXydn41ufn-9Xo-u5nYaVkOE0GdUEII2lSSusbBkgE3TCxB0KUsG9kwpxi3rLYoAlmBKblQqK2FqkTFzorrPddFs9Lr5HvsR0fj9S4RU6tNws470EbZpbV1PXW143hkzS1nhiswwLGArIs9az0u8WksDjWZ7gh6XAn-p27jnS6poFIwhoQP94QUf4-QB937bKHrTIA4Zl1Jie_Gldpe9v6JdBXHFHBWW1U1RY04ULUGO_ChiXix3UL1rK4rqqTaqc7_o8LPQe9tDNB4zB8Z6N5gU8w5QfPYZEn1djX109VEy7vD4TwaHnaR_QOpwuNH</recordid><startdate>20231001</startdate><enddate>20231001</enddate><creator>Günaydın, Fatma Esra</creator><creator>Belen, Erdal</creator><creator>Altın, Sedat</creator><creator>Demir, Ahmet Uğur</creator><creator>Güven, Gülden</creator><creator>Durmuş, Gündüz</creator><general>MDPI AG</general><general>MDPI</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-9268-1071</orcidid></search><sort><creationdate>20231001</creationdate><title>Assessment of Knowledge, Attitude, and Practice Patterns in Pulmonary Arterial Hypertension among Cardiologists and Pulmonologists: Evidence from Turkey</title><author>Günaydın, Fatma Esra ; Belen, Erdal ; Altın, Sedat ; Demir, Ahmet Uğur ; Güven, Gülden ; Durmuş, Gündüz</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c511t-60d696660f280dfdeb3e4a36be60b81f8f3d934c37c660e82ea146980d7692623</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Adult</topic><topic>Cardiologists</topic><topic>Cardiology</topic><topic>Chronic diseases</topic><topic>Clinical medicine</topic><topic>diagnosis</topic><topic>disease management</topic><topic>Dyspnea</topic><topic>education</topic><topic>Endothelin</topic><topic>guideline adherence</topic><topic>Health Knowledge, Attitudes, Practice</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Hypertension, Pulmonary - etiology</topic><topic>Lung transplants</topic><topic>Medical diagnosis</topic><topic>Medical societies</topic><topic>Medicine</topic><topic>Mortality</topic><topic>Patient compliance</topic><topic>Patients</topic><topic>Phosphodiesterase 5 Inhibitors - therapeutic use</topic><topic>Physicians</topic><topic>Practice</topic><topic>pulmonary arterial hypertension</topic><topic>Pulmonary Arterial Hypertension - complications</topic><topic>Pulmonary Arterial Hypertension - drug therapy</topic><topic>Pulmonary arteries</topic><topic>Pulmonary hypertension</topic><topic>Pulmonologists</topic><topic>questionnaire</topic><topic>Questionnaires</topic><topic>Society</topic><topic>Surveys</topic><topic>Turkey</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Günaydın, Fatma Esra</creatorcontrib><creatorcontrib>Belen, Erdal</creatorcontrib><creatorcontrib>Altın, Sedat</creatorcontrib><creatorcontrib>Demir, Ahmet Uğur</creatorcontrib><creatorcontrib>Güven, Gülden</creatorcontrib><creatorcontrib>Durmuş, Gündüz</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Open Access: DOAJ - Directory of Open Access Journals</collection><jtitle>Medicina (Kaunas, Lithuania)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Günaydın, Fatma Esra</au><au>Belen, Erdal</au><au>Altın, Sedat</au><au>Demir, Ahmet Uğur</au><au>Güven, Gülden</au><au>Durmuş, Gündüz</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Assessment of Knowledge, Attitude, and Practice Patterns in Pulmonary Arterial Hypertension among Cardiologists and Pulmonologists: Evidence from Turkey</atitle><jtitle>Medicina (Kaunas, Lithuania)</jtitle><addtitle>Medicina (Kaunas)</addtitle><date>2023-10-01</date><risdate>2023</risdate><volume>59</volume><issue>10</issue><spage>1869</spage><pages>1869-</pages><issn>1648-9144</issn><issn>1010-660X</issn><eissn>1648-9144</eissn><abstract>: Pulmonary arterial hypertension (PAH) is a rare chronic disease of the small pulmonary arteries that causes right heart failure and death. Accurate management of PAH is necessary to decrease morbidity and mortality. Understanding current practices and perspectives on PAH is important. For this purpose, we intended to determine physicians' knowledge, attitudes, and practice patterns in adult pulmonary arterial hypertension (PAH) in Turkey. : Between January and February 2022, an online questionnaire was sent via e-mail to all cardiologists and pulmonologists who were members of the Turkish Society of Cardiology (TSC) and the Turkish Thoracic Society (TTS). : A total of 200 physicians (122 pulmonologists and 78 cardiologists) responded to the questionnaire. Cardiologists were more frequently involved in the primary diagnosis and treatment of PAH than pulmonologists (37.2% vs. 23.8%, = 0.042). More than half of the physicians had access to right heart catheterization. In mild/moderate PAH patients with a negative vasoreactivity test, the monotherapy option was most preferred (82.8%) and endothelin receptor antagonists (ERAs) were the most preferred group in these patients (73%). ERAs plus phosphodiesterase-5 inhibitors (PDE-5 INH) were the most preferred (69%) combination therapy, and prostacyclin analogues plus PDE-5 INH was preferred by only pulmonologists. : Overall, clinical management of patients with PAH complied with guideline recommendations. Effective clinical management of PAH in specialized centers that having right heart catheterization achieve better outcomes.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>37893587</pmid><doi>10.3390/medicina59101869</doi><orcidid>https://orcid.org/0000-0002-9268-1071</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1648-9144
ispartof Medicina (Kaunas, Lithuania), 2023-10, Vol.59 (10), p.1869
issn 1648-9144
1010-660X
1648-9144
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_a9cbcc775d7d47d4874c43a49eae4cc7
source Open Access: PubMed Central; Publicly Available Content (ProQuest)
subjects Adult
Cardiologists
Cardiology
Chronic diseases
Clinical medicine
diagnosis
disease management
Dyspnea
education
Endothelin
guideline adherence
Health Knowledge, Attitudes, Practice
Hospitals
Humans
Hypertension, Pulmonary - etiology
Lung transplants
Medical diagnosis
Medical societies
Medicine
Mortality
Patient compliance
Patients
Phosphodiesterase 5 Inhibitors - therapeutic use
Physicians
Practice
pulmonary arterial hypertension
Pulmonary Arterial Hypertension - complications
Pulmonary Arterial Hypertension - drug therapy
Pulmonary arteries
Pulmonary hypertension
Pulmonologists
questionnaire
Questionnaires
Society
Surveys
Turkey
title Assessment of Knowledge, Attitude, and Practice Patterns in Pulmonary Arterial Hypertension among Cardiologists and Pulmonologists: Evidence from Turkey
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T15%3A34%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Assessment%20of%20Knowledge,%20Attitude,%20and%20Practice%20Patterns%20in%20Pulmonary%20Arterial%20Hypertension%20among%20Cardiologists%20and%20Pulmonologists:%20Evidence%20from%20Turkey&rft.jtitle=Medicina%20(Kaunas,%20Lithuania)&rft.au=G%C3%BCnayd%C4%B1n,%20Fatma%20Esra&rft.date=2023-10-01&rft.volume=59&rft.issue=10&rft.spage=1869&rft.pages=1869-&rft.issn=1648-9144&rft.eissn=1648-9144&rft_id=info:doi/10.3390/medicina59101869&rft_dat=%3Cgale_doaj_%3EA772098967%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c511t-60d696660f280dfdeb3e4a36be60b81f8f3d934c37c660e82ea146980d7692623%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2882599767&rft_id=info:pmid/37893587&rft_galeid=A772098967&rfr_iscdi=true